
NASDAQBasic MaterialsAgricultural Inputs
最新資料
US$0.3283
+US$0.0001 · +0.03%
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
前收盤價
US$0.3283
+US$0.0001 · +0.03%
盤中時間採用ET。市場資料可能有所延遲。
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
日內區間
目前US$0.3283
52週區間
目前US$0.3283
盤中時間採用ET。市場資料可能有所延遲。
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
日內區間
目前US$0.3283
52週區間
目前US$0.3283
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.38億 USD | 3.33億 USD | 4.65億 USD | 4.19億 USD | 3.28億 USD |
| 銷貨成本 | 1.55億 USD | 2.05億 USD | 2.83億 USD | 2.39億 USD | 2.02億 USD |
| 毛利 | 8240萬 USD | 1.28億 USD | 1.82億 USD | 1.8億 USD | 1.26億 USD |
| 研究與開發 | — | 1491.48萬 USD | 1718.3萬 USD | 1534.53萬 USD | 694.75萬 USD |
| 銷售、一般及管理費用 | 8230萬 USD | 8834.52萬 USD | 9426.66萬 USD | 8554.06萬 USD | 5735.9萬 USD |
| 營業費用 | 8230萬 USD | 1.29億 USD | 1.37億 USD | 1.12億 USD | 8490.51萬 USD |
| 利息支出 | 5090萬 USD | 2562.99萬 USD | 2687.2萬 USD | 2378.81萬 USD | 1792.62萬 USD |
| 折舊和攤銷 | — | 2218.22萬 USD | 2129.53萬 USD | 1939.06萬 USD | 918.79萬 USD |
| 營業利益 | 10萬 USD | −76.19萬 USD | 4482.1萬 USD | 5418.4萬 USD | 3986.99萬 USD |
| 淨利 | −2.3億 USD | −5541.61萬 USD | 324.3萬 USD | 1877.99萬 USD | −719.96萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$8.00
上漲空間 2336.80%報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。